CSF GLUCOSE INCREASED

CSF GLUCOSE INCREASED was reported 96 times

CSF GLUCOSE INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Methylating Agent [EPC] 1 0.0010
1 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 1 0.0003
2 Osmotic Diuretic [EPC] 1 0.0002
3 Lipid-based Polyene Antifungal [EPC] 2 0.0002
4 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
5 Provitamin D2 Compound [EPC] 3 0.0001
6 Sulfone [EPC] 1 0.0001
7 Barbiturate [EPC] 1 0.0001
8 Polyene Antifungal [EPC] 3 0.0001
9 Parenteral Iron Replacement [EPC] 1 0.0001
10 Oxazolidinone Antibacterial [EPC] 2 0.0001
11 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
12 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
13 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
14 gamma-Aminobutyric Acid-ergic Agonist [EPC] 4 0.0000
15 Antimycobacterial [EPC] 1 0.0000
16 Mood Stabilizer [EPC] 9 0.0000
17 Typical Antipsychotic [EPC] 1 0.0000
18 Topoisomerase Inhibitor [EPC] 3 0.0000
19 Azole Antifungal [EPC] 5 0.0000
20 Anti-epileptic Agent [EPC] 7 0.0000
21 Sympathomimetic-like Agent [EPC] 1 0.0000
22 Fluoroquinolone Antibacterial [EPC] 4 0.0000
23 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
24 Glycopeptide Antibacterial [EPC] 2 0.0000
25 Nitroimidazole Antimicrobial [EPC] 2 0.0000
26 Penem Antibacterial [EPC] 1 0.0000
27 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
28 Interleukin-17A Antagonist [EPC] 1 0.0000
29 Estrogen Receptor Antagonist [EPC] 1 0.0000
30 Alkylating Drug [EPC] 6 0.0000
31 Thiazide-like Diuretic [EPC] 1 0.0000
32 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
33 General Anesthetic [EPC] 1 0.0000
34 Amide Local Anesthetic [EPC] 2 0.0000
35 Central Nervous System Stimulant [EPC] 2 0.0000
36 Aminoglycoside Antibacterial [EPC] 1 0.0000
37 Atypical Antipsychotic [EPC] 10 0.0000
38 beta3-Adrenergic Agonist [EPC] 1 0.0000
39 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
40 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
41 Antiarrhythmic [EPC] 2 0.0000
42 Ester Local Anesthetic [EPC] 1 0.0000
43 Benzodiazepine [EPC] 13 0.0000
44 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
45 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
46 Methylxanthine [EPC] 1 0.0000
47 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
48 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
49 Cholinergic Nicotinic Agonist [EPC] 1 0.0000
50 BCL-2 Inhibitor [EPC] 1 0.0000
51 Platinum-based Drug [EPC] 4 0.0000
52 Cardiac Glycoside [EPC] 1 0.0000
53 Loop Diuretic [EPC] 6 0.0000
54 Non-Standardized Chemical Allergen [EPC] 1 0.0000
55 Catecholamine [EPC] 1 0.0000
56 Microtubule Inhibitor [EPC] 2 0.0000
57 Integrin Receptor Antagonist [EPC] 1 0.0000
58 Opioid Agonist [EPC] 3 0.0000
59 Nonsteroidal Anti-inflammatory Drug [EPC] 13 0.0000
60 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
61 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
62 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
63 Aromatase Inhibitor [EPC] 1 0.0000
64 Platelet Aggregation Inhibitor [EPC] 5 0.0000
65 Sulfonylurea [EPC] 1 0.0000
66 Corticosteroid [EPC] 10 0.0000
67 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
68 Leukocyte Growth Factor [EPC] 1 0.0000
69 Osmotic Laxative [EPC] 2 0.0000
70 Calcium [EPC] 1 0.0000
71 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
72 Estrogen [EPC] 1 0.0000
73 Interferon beta [EPC] 1 0.0000
74 Expectorant [EPC] 1 0.0000
75 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
76 Kinase Inhibitor [EPC] 2 0.0000
77 Proton Pump Inhibitor [EPC] 2 0.0000
78 beta-Adrenergic Blocker [EPC] 1 0.0000
79 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
80 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
81 GLP-1 Receptor Agonist [EPC] 1 0.0000
82 Insulin Analog [EPC] 1 0.0000
83 Tumor Necrosis Factor Blocker [EPC] 2 0.0000